Seco/Warwick SA (SWG)
Warsaw Stock Exchange · Poland · prices in PLN · close of 22 Oct 2026
Key indicators
| Last close | PLN 35.00 |
|---|---|
| 52-week range | 26.40 – 47.00 |
| Return, 1 month / 3 months | +2.9% / −6.4% |
| Return, 1 year / 3 years | +28.5% / +33.5% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 38.1% |
| Worst drawdown (1 year) | -22.9% |
| Average daily value traded | 0.02M PLN |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Seco/Warwick SA is a Polish maker of industrial furnaces and heat treatment equipment, based in Swiebodzin. The company designs and builds vacuum furnaces, atmosphere furnaces, and systems for processes such as brazing, sintering, and hardening. Its customers are manufacturers and commercial heat treaters in industries including automotive, aerospace, tooling, and metalworking, who use the equipment to treat metal parts. Seco/Warwick also provides related services and spare parts for its installed equipment.
Seco/Warwick SA trades under the code SWG on the Warsaw Stock Exchange in Poland, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Seco/Warwick SA (SWG) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 35.00 on 22 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 244 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 28.5% and over the last three months it fell 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.3% | ||
| From 52-week high | -20.5% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.4% | ||
| 6-month return | 1.7% | ||
| 12-month return, skipping the last month | 24.8% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.9% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M PLN | ||
| Zero-volume days | 3.3% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | +2.9% |
| 3 months | −6.4% |
| 6 months | +1.7% |
| 1 year | +28.5% |
| 3 years | +33.5% |
| 5 years | +161.6% |
Signals
| 50-day / 200-day average | 34.97 / 35.10 |
|---|---|
| Golden / death cross (60 days) | Death, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | PLN 1.2000 |
| 13 Jun 2025 | PLN 1.0000 |
| 17 Jun 2024 | PLN 1.0000 |
| 14 Jun 2023 | PLN 1.0000 |
| 14 Jun 2022 | PLN 0.3000 |
| 30 Jun 2021 | PLN 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.